In today’s recent session, 0.44 million shares of the Milestone Pharmaceuticals Inc (NASDAQ:MIST) have been traded, and its beta is 0.89. Most recently the company’s share price was $1.54, and it changed around $0.0 or 0.06% from the last close, which brings the market valuation of the company to $82.38M. MIST at last check was trading at a discount to its 52-week high of $2.75, offering almost -78.57% off that amount. The share price’s 52-week low was $0.63, which indicates that the recent value has risen by an impressive 59.09% since then. We note from Milestone Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 0.83 million shares, with the 3-month average coming to 2.53 million.
Milestone Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended MIST as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Milestone Pharmaceuticals Inc is expected to report earnings per share of -0.19 for the current quarter.
Milestone Pharmaceuticals Inc (NASDAQ:MIST) trade information
Instantly MIST has been showing a green trend so far today with a performance of 0.06% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.5950 on recent trading dayincreased the stock’s daily price by 3.45%. The company’s shares are currently down -34.71% year-to-date, but still up 19.45% over the last five days. On the other hand, Milestone Pharmaceuticals Inc (NASDAQ:MIST) is 20.38% up in the 30-day period. We can see from the shorts that 2.37 million shares have been sold at a short interest cover period of 1.11 day(s).
The consensus price target as assigned by Wall Street analysts is $10, which translates to bulls needing to increase their stock price by 84.6% from its current value. Analyst projections state that MIST is forecast to be at a low of $10 and a high of $10.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 28.21%. Milestone Pharmaceuticals Inc earnings are expected to increase by -11.57% in 2025, but the outlook is positive 7.52% per year for the next five years.
MIST Dividends
Milestone Pharmaceuticals Inc’s next quarterly earnings report is expected to be released on 2025-May-13.
Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.71% of Milestone Pharmaceuticals Inc shares, and 22.28% of them are in the hands of institutional investors. The stock currently has a share float of 23.39%. Milestone Pharmaceuticals Inc stock is held by 49.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 7.5135% of the shares, which is about 4.97 million shares worth $6.56 million.
RTW INVESTMENTS, LP, with 4.9211% or 3.26 million shares worth $4.3 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF and Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 850.0 shares worth $1.33 million, making up 1.59% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund held roughly 19.87 shares worth around $30990.0, which represents about 0.04% of the total shares outstanding.
